1. Zaniewski E, Skrivankova VW, Brazier E, Avihingsanon A, et al.
   Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
   AIDS 2024.
   


2. Eustaquio PC, Burnett J, Prejean J, Chapin-Bardales J, et al.
   Changes in HIV Pre-exposure Prophylaxis Awareness and Use Among Males Who Inject Drugs Who Have Sex with Men by Sexual Identity, 19 US Urban Areas, 2018 & 2022.
   AIDS 2024.
   


3. Zhao R, Sanstead E, Alarid-Escudero F, Huchko M, et al.
   Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.
   AIDS 2024.
   


4. Ruderman SA, Willig AL, Cleveland JD, Burkholder G, et al.
   Low food security is associated with frailty status and frailty components among people with HIV.
   AIDS 2024.
   


5. Filip I.
   Perinatal exposure to HIV leaves a lasting neurocognitive mark - even when vertical transmission is prevented.
   AIDS 2024.
   


6. Walmsley S.
   Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for AIDS Research and Human Retroviruses.
   AIDS Res Hum Retroviruses 2024;40:501.
   


7. Anderson D, Ramgopal M, Hagins DP, Lee J, et al.
   DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related Weight Gain.
   Clin Infect Dis 2024.
   


8. Eke AC, Brummel SS, Aliyu MH, Stranix-Chibanda L, et al.
   Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy.
   Clin Infect Dis 2024.
   


9. Batohi N, Shalekoff S, Martinson NA, Ebrahim O, et al.
   HIV-1 Elite Controllers are Characterised by Elevated Levels of CD69-Expressing Natural Killer Cells.
   J Acquir Immune Defic Syndr 2024.
   


10. De Scheerder MA, Degroote S, Delporte M, Kiselinova M, et al.
    In depth analysis of the HIV reservoir confirms effectiveness and safety of DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA).
    J Infect Dis 2024.
    


11. Janes H, Fisher LH, Kee JJ, Parameswaran L, et al.
    Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
    J Infect Dis 2024.
    


12. Walker NF, Schutz C, Ward A, Barr D, et al.
    Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency Virus-Associated Tuberculosis.
    J Infect Dis 2024.
    


13. Lo VT, Lim HA, Jang SS, Kim MC, et al.
    N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum neutralization.
    J Med Virol 2024;96:e29871.
    


14. Agrawal P, Knudsen ML, MacCamy A, Hurlburt NK, et al.
    Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env.
    J Virol 2024.
    


15. Tauzin A, Marchitto L, Belanger E, Benlarbi M, et al.
    Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics.
    J Virol 2024.
    


16. Zhang W, Nilles TL, Bream JH, Li H, et al.
    Breadth and polyfunctionality of T cell responses to human cytomegalovirus in men who have sex with men: relationship with HIV infection and frailty.
    J Virol 2024.
    


17. Kizito S, Nabayinda J, Nabunya P, Ssewamala FM, et al.
    HIV and tuberculosis in Uganda: are we neglecting poverty?
    Lancet 2024;404:844-845.
    


18. Saez-Cirion A, Mamez AC, Avettand-Fenoel V, Nabergoj M, et al.
    Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
    Nat Med 2024.
    

Display articles in

• Abstract format
• Medline format